Patient guide

Purple Punch

Background Purple Punch, an Indica Dominant Hybrid comprising 80% Indica and 20% Sativa, is a strain bred through the union of Larry OG and Granddaddy Purple. With a

11 June 2026 2 min read min read

Background

Purple Punch, an Indica Dominant Hybrid comprising 80% Indica and 20% Sativa, is a strain bred through the union of Larry OG and Granddaddy Purple. With a strikingly sweet aroma and powerful effects, Purple Punch delivers a high potentcy THC range of 19.12 – 20.52% and a variable CBD content of 0.64 – 5.56%.

Bag Appeal

Purple Punch presents dense, frosty buds lavished with trichomes, exuding a grape aroma. The buds are deep purple in hue, interspersed with bright orange pistils.

Aroma & Flavour

The strain has a potent, grape-centric aroma, similar to Granddaddy Purple, its progenitor. This aroma translates into a rich, grape-flavoured taste profile complemented by other fruity undertones, reminiscent of grape candy, blueberry muffins, and tart Kool-Aid.

Terpenes

Purple Punch’s terpene profile is led by Caryophyllene, followed by Limonene and Pinene. These contribute to its distinctive spicy, peppery notes with undertones of citrus and pine.

Summary

Purple Punch is an Indica Dominant Hybrid, prized for its dessert-like qualities and effectiveness in therapeutic application. With a potent THC content and a unique terpene blend, this strain may be well-suited for patients requiring cultivars on the more relaxing end of the spectrum.

Sources and Research

Note: Educational purposes only. Always consult a qualified medical professional. Evidence levels vary.

Sources and References

GeneticsNot Specified
Irradiated or notIrradiated
Alternative NamesPunch
BreederUnknown
Max THC20.52
Max CBD5.56
Terpene ProfileCaryophyllene, Limonene, Pinene
Strain TypeIndica-dominant
Strain SummaryPurple Punch is an Indica Dominant Hybrid, prized for its dessert-like qualities and effectiveness in therapeutic application. With a potent THC content and a unique terpene blend, this strain may be well-suited for patients requiring cultivars on the more relaxing end of the spectrum.
Available CBPMsHexacan® HEXA03 T20
Patient InsightNo data added yet - please take a few minutes share your insight using the link above.